Buy Us a Cup of Coffee

Malvern-based Venatorx Pharmaceuticals Joins the Alliance for Biosecurity

VenatoRx Pharmaceuticals

MALVERN, PA — Venatorx Pharmaceuticals announced that it joined the Alliance for Biosecurity, a coalition of biopharmaceutical companies – along with laboratory and academic partners – that promotes a strong public-private partnership in order to ensure the medical countermeasures that protect public health are effective and readily available.

We welcome Venatorx Pharmaceuticals to the Alliance,” said Alliance for Biosecurity Co-Chair, Brent MacGregor. “Our 18 member companies, including Venatorx, provide a wide array of expertise and perspectives that contribute to our expanding scope. Together, we are uniquely equipped to help guide and further develop public-private partnerships that protect the American people from chemical, biological, radiological or nuclear threats.”

The Alliance for Biosecurity supports national health security by advocating for public policies and funding to support the rapid development, production, stockpiling, and distribution of critically needed medical countermeasures that are used to prevent and respond to a variety of threats.

READ:  Galera Therapeutics to Host Virtual KOL Event on Cisplatin-Induced Chronic Kidney Disease

“Antibiotics represent a critical component to effectively respond to public health emergencies involving chemical, biological, radiological, or nuclear (CBRN) threats. Venatorx is developing antibiotic candidates that have the potential to effectively treat a number of bacterial bioterrorism pathogens, and possibly prevent opportunistic infections in patients who have been exposed to radiation or who require prolonged hospitalization,” said Joseph C. Larsen, Ph.D., Vice President, Strategic Portfolio Development at Venatorx. “Our partnership with the Alliance for Biosecurity is part of our overall strategy to overcome the market challenges facing antibiotic development by pursuing conventional and public health emergency preparedness applications for our development-stage and discovery-stage products.”

“Because the U.S. government creates the demand for these products by authorizing funding for procurement and development, it benefits both sides to have clarity of requirements so industry can adequately meet the government’s needs,” said Alliance for Biosecurity Co-Chair, Chris Frech. “In the interest of preparedness and national security, it is imperative that industry and government work together to ensure that the necessary countermeasures are developed, manufactured, and delivered to the strategic national stockpile or that the infrastructure exists to respond to such emergencies. For the Alliance to represent industry accurately in these situations, it is important that we have well-rounded knowledge to bring to these public-private partnerships. Our new members help give us a vast scope of expertise behind the same singular focus: strong and resilient national health security.”

READ:  Galera Therapeutics to Host Virtual KOL Event on Cisplatin-Induced Chronic Kidney Disease

Source: VenatoRx Pharmaceuticals Inc., 30 Spring Mill Drive, Malvern PA 19355

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee